All
Taking Action To Address Lung Cancer Across the US
March 2nd 2018Researchers studied state-specific measures of disease incidence, adult smoking prevalence, radon zones, five-year survival, stage at diagnosis, five-year survival by stage at diagnosis, surgery as part of the first course of treatment and accredited lung cancer screening centers.
Number of Cancerous Lymph Nodes May Predict Head and Neck Cancer Survival
March 1st 2018A variety of factors go in to the staging of a head and neck cancer diagnosis, however, the number of malignant lymph nodes may very well be the key to prognosis and treatment moving forward in this patient population.
Late Effects Burden Lymphoma Survivors After Multimodality Treatment
February 28th 2018Many patients with lymphoma need treatment with both chemotherapy and radiation, but these treatments may be accompanied by significant late-term effects, according to a new study presented during the 2018 American Society of Clinical Oncology Cancer Survivorship Symposium.
FDA Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer
February 27th 2018The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.